BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 8:11:25 AM | Browse: 1058 | Download: 1978
 |
Received |
|
2020-12-21 09:35 |
|
Peer-Review Started |
|
2020-12-21 09:38 |
|
First Decision by Editorial Office Director |
|
2021-01-11 05:00 |
|
Return for Revision |
|
2021-01-11 05:00 |
|
Revised |
|
2021-01-14 16:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-02-24 06:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-11 03:08 |
|
Articles in Press |
|
2021-03-11 03:08 |
|
Edit the Manuscript by Language Editor |
|
2021-03-19 01:38 |
|
Typeset the Manuscript |
|
2021-03-25 01:18 |
|
Publish the Manuscript Online |
|
2021-04-09 08:11 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ming-Cheng Guan, Ming-Da Wang, Si-Yu Liu, Wei Ouyang, Lei Liang, Timothy M Pawlik, Qiu-Ran Xu, Dong-Sheng Huang, Feng Shen, Hong Zhu and Tian Yang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
81972726 |
|
| Corresponding Author |
Tian Yang, MD, Doctor, Doctor, Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital (Navy Medical University), Second Military Medical University, No. 225, Changhai Road, Shanghai 200438, China. yangtian6666@hotmail.com |
| Key Words |
Hepatocellular carcinoma; Early detection; Biomarker; Therapeutic strategies; Immunotherapeutic innovations |
| Core Tip |
Long-term survival relies upon early diagnosis and timely treatment for patients with hepatocellular carcinoma. In this review, an update on the non-invasive early molecular detection and therapeutic strategies associated with hepatocellular carcinoma is discussed, focusing on omics-related biomarkers (e.g., proteins, metabolites, circulating tumor deoxyribonucleic acid, circulating non-coding ribonucleic acid), locoregional and systemic therapies for treating different stage hepatocellular carcinoma, as well as potential immunotherapeutic innovations (e.g., adoptive cell transfer therapy). |
| Publish Date |
2021-04-09 08:11 |
| Citation |
Guan MC, Wang MD, Liu SY, Ouyang W, Liang L, Pawlik TM, Xu QR, Huang DS, Shen F, Zhu H, Yang T. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World J Gastrointest Oncol 2021; 13(4): 197-215
|
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i4/197.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i4.197 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
